LDLR and hepatocellular carcinoma: Using lipopolysaccharide (LPS) as a treatment for hepatocellular carcinoma (HCC), He et al. (2017) demonstrated that the increased internal cholesterol concentrations were due to upregulation of LDLR and HMGCR.